Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine




Disease psoriasis
Comorbidity C0041296|tuberculosis
Sentences 16
PubMedID- 25120233 Latent tuberculosis reactivation in a patient with erythrodermic psoriasis under treatment with ustekinumab and a low dose steroid, despite isoniazid chemoprophylaxis.
PubMedID- 23909256 Interferon-gamma release assay for tuberculosis in patients with psoriasis treated with tumour necrosis factor antagonists: in vivo and in vitro analysis.
PubMedID- 22529801 Moreover, in one study the in vitro t cell responsiveness was diminished towards mycobacterium tuberculosis in cases with severe psoriasis [4].
PubMedID- 21987138 Investigation of latent tuberculosis infection in patients with psoriasis who are candidate for receiving immunobiological drugs.
PubMedID- 23278714 Evaluating the use of the interferon-gamma response to mycobacterium tuberculosis-specific antigens in patients with psoriasis prior to antitumour necrosis factor-alpha therapy: a prospective head-to-head cross-sectional study.
PubMedID- 25753908 The risk of tuberculosis in patients with psoriasis treated with anti-tumor necrosis factor agents.
PubMedID- 23375515 Association between traditional systemic antipsoriatic drugs and tuberculosis risk in patients with psoriasis with or without psoriatic arthritis: results of a nationwide cohort study from taiwan.
PubMedID- 23786208 Isoniazid therapy for latent tuberculosis in psoriasis patients receiving biological agents: is it safe and efficacious.
PubMedID- 21083541 Within the asia-pacific region, the tuberculosis risk in patients with psoriasis who use tumour necrosis factor (tnf) blockers is unknown.
PubMedID- 21629971 Evaluation of an ifn-gamma assay in the diagnosis of latent tuberculosis in patients with psoriasis in a highly endemic setting.
PubMedID- 25612132 Pulmonary sarcoidosis and latent tuberculosis in a patient with psoriasis treated with adalimumab.
PubMedID- 23094309 Severe psoriasis with positive tuberculosis test and treatment with biologic therapy: a case report.
PubMedID- 21623925 Infliximab partially impairs the anti-mycobacterium tuberculosis immune responses of severe psoriasis patients with positive tuberculin skin-test.
PubMedID- 24863903 Latent tuberculosis infection in patients with chronic plaque psoriasis who are candidates for biological therapy.
PubMedID- 21054332 Diagnosing latent tuberculosis infection in patients with psoriasis under antitumour necrosis factor-alpha treatment: every new solution breeds new doubts.
PubMedID- 19609541 However, it is not known whether the chronically activated immune system of psoriasis patients interferes with their mycobacterium tuberculosis (mtb)-specific immunity, especially in tuberculosis-endemic areas like brazil.

Page: 1